Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COINCIDE-RT
NCT07856719Phase 2Not yet recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2027
- Primary completion
- Jul 2032
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in carotid artery disease, sponsored by University of Texas MD Anderson Cancer Center. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT07856719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07856719.